Vericiguat Market
Vericiguat Market Size, Share & Industry Analysis, By Manufacturer Type (In-house API manufacturers, and Third-party/Outsourced manufacturers), By Application (Chronic Heart Failure (CHF) (Primary segment), Cardiovascular Disease Research, and Others), By End-User (Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), and Academic & Research Institutes), Forecast 2025–2035
Vericiguat API market is projected to grow at a CAGR of 6.8% between 2025 and 2035. The market growth is driven by the rising global burden of chronic heart failure (CHF) and the increasing adoption of novel cardiovascular therapies. Vericiguat, a soluble guanylate cyclase (sGC) stimulator, has gained recognition as a breakthrough treatment for patients with symptomatic chronic heart failure with reduced ejection fraction (HFrEF).
Among various segments, the pharmaceutical-grade API for chronic heart failure holds the largest share due to the approved use of Vericiguat under brand names such as Verquvo in the United States and Europe. Pharmaceutical companies and contract manufacturing organizations (CMOs) dominate the end-user segment, as they focus on the commercial-scale production of high-purity APIs for branded formulations. The demand is also increasing among contract research organizations (CROs) and academic institutions for clinical trial supply and research purposes.
Geographically, North America, particularly the US, represents the largest market for vericiguat API, owing to early FDA approval, high disease prevalence, and the strong presence of major pharmaceutical players. Europe follows closely, with Germany and the UK being key markets due to Bayer’s strong footprint. The Asia-Pacific region, especially India and China, is emerging as a significant contributor due to the presence of cost-efficient API manufacturing hubs and growing cardiovascular disease prevalence.
Prominent players in the market include Bayer AG, Merck & Co., Inc., and several leading API manufacturers such as Dr. Reddy’s Laboratories, Lupin Limited, and Zhejiang Hisun Pharmaceutical. These companies are focusing on strategic collaborations, API supply agreements, and innovation in production technologies to maintain competitiveness.
Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts
Report Scope & Segmentation
- Introduction
- Overview of Vericiguat
- Key Applications & Industry Use Cases
- Market Scope & Study Objectives
- Market Overview
- Global Market Size & Growth Trends (Historical & Forecast)
- Market Value & Revenue Analysis
- Demand-Supply Dynamics
- Segmental Outlook
- By Manufacturer Type
- In-house API manufacturers
- Third-party/Outsourced manufacturers
- By Application
- Chronic Heart Failure (CHF)
- Cardiovascular Disease Research
- Others
- By End-User
- Pharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- By Manufacturer Type
- In-house API manufacturers
- Third-party/Outsourced manufacturers
- Price Analysis
- Current Price Trends (Per kg & Per Ton)
- Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
- Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
- Production & Supply Volume
- Global Production Capacity & Key Manufacturers
- Production Process & Technological Developments
- Raw Material Analysis
- Trade Analysis (Import & Export)
- Major Exporting & Importing Countries
- Trade Volume & Value Statistics
- Impact of Trade Regulations & Policies
- Regional Analysis
- North America (US and Canada)
- Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
- Rest of the World (Latin America, Middle East, and Africa)
- Competitive Landscape
- Top Global Manufacturers & Market Share
- Company Profiles & Key Developments
- Mergers, Acquisitions & Investments
- Regulatory & Compliance Factors
- FDA, REACH, and Other Regulatory Frameworks
- Environmental & Safety Considerations
- Emerging Policies Impacting Market Growth
- Conclusion & Strategic Recommendations
- Key Takeaways for Stakeholders
- Market Entry Strategies
- Frequently Asked Questions
- Choose License Type
$3600/- Multi User License
- Why Choose us?
- Experienced in market research and consulting.
- Seasoned professionals with diverse industry knowledge.
- Proven track record in delivering valuable insights.
- Tailored methodologies for unique client needs.
- End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
- Latest tools and tech for data collection, analysis, and visualization.
- Embrace of AI and machine learning for deeper insights.
- Global capabilities and extensive network.
- In-depth understanding of international markets, trends, and regulations.
- Dedicated to addressing specific client needs and goals.
- Focus on delivering value through efficient research outcomes.
- Recent posts
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
